Editorial: EU must rethink vaccine strategy after its misstep
By underestimating the logistics of a mass vaccination rollout, European leaders risk failing their citizens on this vital issue
AstraZeneca has made few friends in the weeks since it unveiled a Covid-19 vaccine along with Oxford University. Since that joint achievement, the vaccine has been clouded by doubts, and an impression that the Anglo-Swedish pharmaceutical company’s focus is as much on the stock market as on the pandemic.
During testing of the vaccine, AstraZeneca got into a row with the US Food and Drug Administration over the conduct of a clinical trial....
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Editorial: Setting up new climate courts cannot happen soon enough
With legal challenges against government climate policy decisions mounting by the week, time is of the essence
Editorial: Government guilty of political naivety on Zappone appointment
The decision to make the former TD a special UN envoy for freedom of expression has caused huge embarrassment to an already fragile coalition
Editorial: Johnson and Frost must accept consequences of NI protocol
The EU says it will offer maximum flexibility on tweaking special trading arrangement for the North. But we have yet to see any reciprocal moves on London’s part
Editorial: Hospitality sector will continue to need support after reopening
The regulations facing pubs add another level of stress for owners, but without them the sector could be facing a second lost summer